⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 1, 2024Cancer MedicineOpen Access

Radiotherapy and chemoradiotherapy for postoperative recurrence in patients with esophageal squamous cell carcinoma

Qing Liu Xue-Hua Tu Ruixuan Yu Hong‐Ying Wen Xiaoguang Guo Daiyuan Ma K Jiang Dong Tian

View Full Paper

Ask AI

Bookmark

Share

Abstract

The optimal treatment for esophageal squamous cell carcinoma (ESCC) patients with postoperative recurrence remains controversial. We aimed to evaluate the effects of radiotherapy (RT) and chemoradiotherapy (CRT) on postoperative recurrence in ESCC patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Liu et al. (2024) studied this question.

synapsesocial.com/papers/68e5dfd6b6db64358757446a https://doi.org/10.1002/cam4.70108

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Comparison of the Clinical Outcomes of Esophagectomy and Concurrent Chemoradiotherapy in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma2024 · 1 citations
2Postoperative Lymph Node Recurrence in Esophageal Cancer After Surgery and Prognosis of Chemoradiotherapy2024 · 2 citations
3Induction chemotherapy followed by definitive chemoradiation in patients with inoperable esophageal squamous cell carcinoma: a multicenter retrospective study2025
4Long-term survival, recurrence patterns, and postrecurrence outcomes after neoadjuvant chemoradiotherapy versus surgery plus adjuvant therapy in locally advanced esophageal squamous cell carcinoma: Final results of a randomized phase III trial.RCT · 2026
5Impact of intensity-modulated radiotherapy on survival and pulmonary toxicities for localized esophageal squamous cell carcinomaReview · 2026

More related papers

Concurrent chemoradiotherapyof different radiation doses and different irradiation fields for locally advanced thoracic esophageal squamous cell carcinoma: A randomized, multicenter, phase III clinical trial2024
Real-world study of first-line immunotherapy combined with chemoradiotherapy in esophageal squamous cell carcinoma2025
Treatment strategies for postoperative locoregional recurrent esophageal squamous cell carcinoma after curative resection: a narrative review2026

More from Cancer Medicine

Pre‐Existing and Post‐Cancer Major Cardiovascular Disease and Their Association With Mortality Outcomes Among Cancer Survivors in AustraliaThu,
The Effect of Prophylactic Protection of Inferior Parathyroid Gland Vein Blood Supply on Reducing Postoperative HypoparathyroidismThu,